Hardik Parikh
Stock Analyst at JP Morgan
(n/a)
# 4,619
Out of 5,063 analysts
5
Total ratings
20%
Success rate
-49.56%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Hardik Parikh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VKTX Viking Therapeutics | Maintains: Overweight | $80 → $75 | $34.26 | +118.91% | 2 | Oct 24, 2025 | |
| PCRX Pacira BioSciences | Downgrades: Underweight | $45 → $10 | $23.05 | -56.62% | 2 | Aug 12, 2024 | |
| GPCR Structure Therapeutics | Initiates: Overweight | $65 | $34.32 | +89.39% | 1 | May 21, 2024 |
Viking Therapeutics
Oct 24, 2025
Maintains: Overweight
Price Target: $80 → $75
Current: $34.26
Upside: +118.91%
Pacira BioSciences
Aug 12, 2024
Downgrades: Underweight
Price Target: $45 → $10
Current: $23.05
Upside: -56.62%
Structure Therapeutics
May 21, 2024
Initiates: Overweight
Price Target: $65
Current: $34.32
Upside: +89.39%